LA Times Studios
‘Second Opinion,’ Episode 4: The Long-Haulers
- Title
- ‘Second Opinion,’ Episode 4: The Long-Haulers
- Runtime
- 42:07
- Date posted
- 6 years ago
- Description
- Our fourth episode examines the long-term health impact of COVID-19 on survivors of the disease. Los Angeles Times Executive Chairman Dr. Patrick Soon-Shiong, a surgeon and scientist, is joined by Dr. Carlos Cordon-Cardo, professor and chair of the Department of Pathology at the Icahn School of Medicine at Mount Sinai. Dr. Cordon-Cardo’s work offers a unique glimpse at the ways COVID-19 interacts with, and harms, the human body. We will also hear from a group of recovering coronavirus patients who continue to suffer from a variety of symptoms months after contracting COVID-19. The discussion is moderated by Eli Stokols of The Times' Washington bureau.
Dr. Carlos Cordon-Cardo is chair of the Department of Pathology at the Mount Sinai Health System in New York, and a distinguished professor at the Icahn School of Medicine at Mount Sinai, where he teaches pathology, genetics, and the science of cancer. Dr. Cordon-Cardo is known for his work bridging the disciplines of patho...
- Title
- 'Second Opinion' Episode 3: Path to a Vaccine
- Runtime
- 38:25
- Date posted
- 6 years ago
- Description
- “Second Opinion,” a new discussion series produced by L.A. Times Studios in conjunction with the Los Angeles Times newsroom, takes you to the forefront of medical research and conversations about health, science and technology.
In our third episode, Los Angeles Times Executive Chairman Dr. Patrick Soon-Shiong speaks with biologists Alessandro Sette and Shane Crotty, whose research on cellular memory of the coronavirus offers clues about paths to a vaccine against COVID-19. The discussion is moderated by Eli Stokols of The Times' Washington bureau.
Dr. Patrick Soon-Shiong, executive chairman of the Los Angeles Times, is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is the chairman and chief executive of NantWorks, and the owner of or investor in a number of companies, including ImmunityBio and NantKwest, which are currently researching immunotherapies for COVID-19.
...
- Title
- ‘Second Opinion,’ Episode 2: Controlling the Outbreak
- Runtime
- 59:12
- Date posted
- 6 years ago
- Description
- “Second Opinion,” a new discussion series produced by L.A. Times Studios in conjunction with the Los Angeles Times newsroom, takes you to the forefront of medical research and conversations about health, science and technology. Our second episode examines the crucial role of testing to halt the spread of COVID-19.
For this discussion, Los Angeles Times Executive Chairman Dr. Patrick Soon-Shiong, a surgeon and scientist, is joined once more by renowned biologist William Haseltine. Together Soon-Shiong and Haseltine examine how various coronavirus tests work, and explain how members of the public can determine which tests are right for them. The discussion is moderated by Eli Stokols of The Times' Washington bureau.
Dr. Patrick Soon-Shiong, executive chairman of the Los Angeles Times, has spent his career studying the human immune system to fight cancer and infectious diseases. He is the chairman and chief executive of NantWorks, and the owner of or investor...
- Title
- 'Second Opinion,' Episode 1: COVID-19’s resurgence
- Runtime
- 0:00
- Date posted
- 6 years ago
- Description
- “Second Opinion,” a new discussion series presented by the Los Angeles Times, takes you to the forefront of medical research and conversations about health, science and technology.
In our first episode, also available to watch on our app and our YouTube channel, Los Angeles Times Executive Chairman Dr. Patrick Soon-Shiong, a surgeon and scientist, is joined by renowned biologist William Haseltine for a discussion about COVID-19 and the public health implications of its recent resurgence. The discussion is moderated by Eli Stokols of The Times’ Washington bureau.
Dr. Patrick Soon-Shiong, executive chairman of the Los Angeles Times, is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is the chairman and chief executive of NantWorks, and the owner of or investor in a number of companies, including ImmunityBio and NantKwest, which are currently researching immunotherapies for COVID-...
- Title
- The Science Behind the Coronavirus, Series II
- Runtime
- 1:24:54
- Date posted
- 7 years ago
- Description
- In this second installment of our “The Science Behind the Coronavirus” series, Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times, continues his examination of the ways the scientific community is taking up the battle against COVID-19.
Soon-Shiong (MD, MBBCh, MSc, FRCS (C), FACS) begins his presentation with a warning: The virus is continuing to mutate and is here to stay. But, Soon-Shiong adds, there is hope. Over an introduction and six parts, Soon-Shiong explains how scientists around the world are considering treating patients suffering from stages of COVID-19.
Finally, Soon-Shiong breaks down the medical concepts researchers are pondering as they search for a vaccine. Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is also the chairman and chief executive of NantWorks and the owner of or investor in a number of companies, including Immun...
- Title
- Introduction: The Science Behind the Coronavirus, Series II
- Runtime
- 8:18
- Date posted
- 7 years ago
- Description
- Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times, offers an overview of the second installment of our “The Science Behind the Coronavirus” series. This second series will examine why COVID-19 is a long-term threat to the global community and what scientists are doing to develop treatments and search for a vaccine.
Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is also the chairman and chief executive of NantWorks and the owner of or investor in a number of companies, including ImmunityBio and NantKwest, which are currently researching immunotherapies for COVID-19.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
LET’S CONNECT:
Facebook ► https://www.facebook.com/latimes
Twitter ► https://twitter.com/LAT...
- Title
- Part 1: COVID-19 Is Here to Stay
- Runtime
- 9:00
- Date posted
- 7 years ago
- Description
- SARS-CoV-2, the virus that causes the COVID-19 disease, has evolved, adapting and mutating as it travels across the globe. In Part 1 of this series, Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times, explains how this evolution has ensured the survival of the coronavirus and made COVID-19 a long-term threat.
Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is also the chairman and chief executive of NantWorks and the owner of or investor in a number of companies, including ImmunityBio and NantKwest, which are currently researching immunotherapies for COVID-19.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
LET’S CONNECT:
Facebook ► https://www.facebook.com/latimes
Twitter ► https://twitter.com/LATimes
...
- Title
- Part 2: Therapeutic Strategies in Motion
- Runtime
- 14:11
- Date posted
- 7 years ago
- Description
- While COVID-19 may be here to stay, there is hope. That’s because scientists have been studying severe acute respiratory syndrome (SARS) since an outbreak in China in 2003 — and the coronavirus ravaging the globe today, SARS-CoV-2, is an offspring of that 2003 virus. In this chapter, Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times, examines treatments scientists are contemplating as they take up the fight against COVID-19.
Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is also the chairman and chief executive of NantWorks and the owner of or investor in a number of companies, including ImmunityBio and NantKwest, which are currently researching immunotherapies for COVID-19.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
...
- Title
- Part 3: The Asymptomatic Patient
- Runtime
- 10:15
- Date posted
- 7 years ago
- Description
- Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times, delves into the first of three kinds of coronavirus patients: the asymptomatic patient. Although projections vary, scientists agree there is a high prevalence of people infected who show no symptoms of COVID-19. This “stage one” patient, Soon-Shiong explains, assumes it’s safe to have contact with others. As long as tests remain widely unavailable, we should all make the assumption we’re potentially positive, says Soon-Shiong, and limit the spread of the disease by staying isolated and wearing a mask in public.
Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is also the chairman and chief executive of NantWorks and the owner of or investor in a number of companies, including ImmunityBio and NantKwest, which are currently researching immunotherapies for COVID-19.
SUBSCRIBE FOR MORE VIDEOS...
- Title
- Part 4: The Symptomatic Patient
- Runtime
- 20:10
- Date posted
- 7 years ago
- Description
- Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times, discusses the second of three kinds of coronavirus patients: the symptomatic patient. This patient is experiencing flu-like symptoms and perhaps other indications of COVID-19, such as the loss of taste and smell, and should be ready to call a physician or seek hospitalization if symptoms worsen. In this chapter, Soon-Shiong offers an overview of drugs already on the market that are being tested as possible treatments for COVID-19. Soon-Shiong also warns about so-called home remedies and the risks of repurposing existing drugs.
Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is also the chairman and chief executive of NantWorks and the owner of or investor in a number of companies, including ImmunityBio and NantKwest, which are currently researching immunotherapies for COVID-19.
SUBSCRIBE FOR MOR...
- Title
- Part 5: The Critical Patient
- Runtime
- 9:21
- Date posted
- 7 years ago
- Description
- Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times, discusses the third category of coronavirus patient: the critical patient. These, Soon-Shiong explains, are the patients filling ICUs across the country, for whom ventilators are needed as COVID-19 constricts their breathing and threatens their lives. Using drawings illustrating the mechanics of the lungs and immune system, Soon-Shiong shows how the body damages itself in the course of fighting the disease. Soon-Shiong goes on to propose that specialized stem cells derived from bone marrow may restrain the immune system and dampen the body’s fatal “cytokine storm.” Among the organizations looking at stem cell treatments are Soon-Shiong’s own biotech companies, ImmunityBio and NantKwest.
Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is also the chairman and chief executive of NantWorks and the owner...
- Title
- Part 6: The Race for a Vaccine
- Runtime
- 14:49
- Date posted
- 7 years ago
- Description
- Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times, closes the second installment of our special series, “The Science Behind the Coronavirus,” with a look at how scientists are exploring ways to develop a COVID-19 vaccine by training the body’s immune system to prevent the infection. Among the companies racing to develop a vaccine is Soon-Shiong’s own company, ImmunityBio.
Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is also the chairman and chief executive of NantWorks and the owner of or investor in a number of companies, including ImmunityBio and NantKwest, which are currently researching immunotherapies for COVID-19.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
LET’S CONNECT:
Facebook ► https://www....
- Title
- The Science Behind the Coronavirus, Series I
- Runtime
- 33:15
- Date posted
- 7 years ago
- Description
- Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times, offers an overview of our special series, The Science Behind the Coronavirus. In this introduction, Soon-Shiong (MD, MBBCh, MSc, FRCS (C), FACS) proposes that understanding how the virus infects our bodies and strategies toward treatment can help us allay our anxiety about it. Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is also the chairman and CEO of NantWorks and the owner of or investor in a number of companies, including ImmunityBio and NantKwest which are currently researching immunotherapies for COVID-19.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
LET’S CONNECT:
Facebook ► https://www.facebook.com/latimes
Twitter ► https://twitter.com/LATimes
Instag...
- Title
- Introduction: Understanding the coronavirus
- Runtime
- 2:54
- Date posted
- 7 years ago
- Description
- Dr. Patrick Soon-Shiong, the owner of the Los Angeles Times, offers an overview of our special series, The Science Behind the Coronavirus. In this introduction, Soon-Shiong proposes that understanding how the virus infects our bodies and strategies toward treatment can help us allay our anxiety about it. Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
LET’S CONNECT:
Facebook ► https://www.facebook.com/latimes
Twitter ► https://twitter.com/LATimes
Instagram ► https://www.instagram.com/latimes
- Title
- Part 1: What is the coronavirus?
- Runtime
- 4:52
- Date posted
- 7 years ago
- Description
- In this segment of our special series, The Science Behind the Coronavirus, Dr. Patrick Soon-Shiong explains the evolution of the coronavirus — how it came to be, and how it interacts with the body. Soon-Shiong is the owner of the Los Angeles Times. He is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
LET’S CONNECT:
Facebook ► https://www.facebook.com/latimes
Twitter ► https://twitter.com/LATimes
Instagram ► https://www.instagram.com/latimes
- Title
- Part 2: How deadly is the coronavirus?
- Runtime
- 4:01
- Date posted
- 7 years ago
- Description
- Dr. Patrick Soon-Shiong continues our special series, The Science Behind the Coronavirus, with a look at the deadly threat of the virus. In later segments, Soon-Shiong will examine what you can do to protect yourself. Soon-Shiong is the owner of the Los Angeles Times and a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
LET’S CONNECT:
Facebook ► https://www.facebook.com/latimes
Twitter ► https://twitter.com/LATimes
Instagram ► https://www.instagram.com/latimes
- Title
- Part 3: How contagious is the coronavirus?
- Runtime
- 2:27
- Date posted
- 7 years ago
- Description
- In this segment of our series The Science Behind the Coronavirus, Dr. Patrick Soon-Shiong examines the speed with which the coronavirus spreads. Soon-Shiong is the owner of the Los Angeles Times and a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
LET’S CONNECT:
Facebook ► https://www.facebook.com/latimes
Twitter ► https://twitter.com/LATimes
Instagram ► https://www.instagram.com/latimes
- Title
- Part 4: Symptoms associated with infection
- Runtime
- 3:32
- Date posted
- 7 years ago
- Description
- Dr. Patrick Soon-Shiong, the owner of the Los Angeles Times, continues our special series, The Science Behind the Coronavirus. In this segment, Soon-Shiong examines the symptoms associated with infection. Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
LET’S CONNECT:
Facebook ► https://www.facebook.com/latimes
Twitter ► https://twitter.com/LATimes
Instagram ► https://www.instagram.com/latimes
- Title
- Part 5: The science of soap
- Runtime
- 3:53
- Date posted
- 7 years ago
- Description
- In this segment of our special series, The Science Behind the Coronavirus, Dr. Patrick Soon-Shiong explains the power of a simple act: washing your hands, and why this act can destroy the envelope of the coronavirus. Soon-Shiong is the owner of the Los Angeles Times and a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
LET’S CONNECT:
Facebook ► https://www.facebook.com/latimes
Twitter ► https://twitter.com/LATimes
Instagram ► https://www.instagram.com/latimes
- Title
- Part 6: Strategies for treatment
- Runtime
- 8:36
- Date posted
- 7 years ago
- Description
- Dr. Patrick Soon-Shiong breaks down methods scientists are contemplating as they seek a treatment for the coronavirus. Soon-Shiong also examines the difference between a treatment and a vaccine. The Science Behind the Coronavirus is a special series offered by the Los Angeles Times. Soon-Shiong is the owner of the Los Angeles Times and a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
LET’S CONNECT:
Facebook ► https://www.facebook.com/latimes
Twitter ► https://twitter.com/LATimes
Instagram ► https://www.instagram.com/latimes
- Title
- Part 7: How long will the pandemic last?
- Runtime
- 3:34
- Date posted
- 7 years ago
- Description
- Dr. Patrick Soon-Shiong examines how long the coronavirus pandemic could last, and how the actions we take — from washing our hands to social distancing — will help “flatten the curve.” The Science Behind the Coronavirus is a special series from the Los Angeles Times. Soon-Shiong is the owner of the Los Angeles Times and a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases.
SUBSCRIBE FOR MORE VIDEOS AND NEWS
http://www.youtube.com/subscription_center?add_user=losangelestimes
https://www.latimes.com/subscription
LET’S CONNECT:
Facebook ► https://www.facebook.com/latimes
Twitter ► https://twitter.com/LATimes
Instagram ► https://www.instagram.com/latimes
